Given the disparity in baseline characteristics between the case and control groups, adjustments were made to investigate the impact of maternal FAS, progeny MTHFD1, and MTHFD2 gene polymorphisms, along with their interactions, on congenital heart disease. This evidence concerns the gene MTHFD2 and congenital heart disease.